Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
J Surg Oncol
    March 2026
  1. SALEHI O, Somasundar P, Espat NJ, Calvino AS, et al
    The Impact of Institutional Volume of Endoscopic Resection on Early-Stage Gastric Cancer Outcomes.
    J Surg Oncol. 2026 Mar 8. doi: 10.1002/jso.70223.
    >> Share

    February 2026
  2. ZHAO H, Sun Q, Jiang X, Xu P, et al
    Mechanisms Influencing Neoadjuvant Treatment Decision-Making in Patients With Locally Advanced Gastric Cancer: An Analysis Based on the Ottawa Decision Support Framework.
    J Surg Oncol. 2026 Feb 10. doi: 10.1002/jso.70205.
    >> Share

    December 2025
  3. CHEN M, Peng J, Lai H, Wang S, et al
    Treatment of Gastric Cancer: Laparoscopic Pylorus-Preserving Gastrectomy or Laparoscopic Distal Gastrectomy? A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 Dec 31. doi: 10.1002/jso.70171.
    >> Share

  4. ZHANG Y
    Severe Complications in Remnant Gastric Cancer: An Epiphenomenon of Tumor Biology and Surgical Complexity?
    J Surg Oncol. 2025 Dec 9. doi: 10.1002/jso.70165.
    >> Share

    November 2025

  5. Correction to "Utilization and Survival Outcomes of Neoadjuvant Chemotherapy for Early-Stage Gastric Cancer".
    J Surg Oncol. 2025 Nov 4. doi: 10.1002/jso.70123.
    >> Share

    September 2025
  6. KUDOU K, Ota M, Ogaki K, Kimura Y, et al
    Risk Factors and Prognostic Significance of Severe Postoperative Complications After Curative Resection for Remnant Gastric Cancer: A Multicenter Retrospective Study.
    J Surg Oncol. 2025 Sep 14. doi: 10.1002/jso.70094.
    >> Share

    August 2025
  7. LEE SM, Kim JY
    Clinicopathologic Factors Influencing Endoscopic Versus Surgical Approaches in Patients With T1b Gastric Carcinoma With Lymphoid Stroma.
    J Surg Oncol. 2025 Aug 14. doi: 10.1002/jso.70053.
    >> Share

    July 2025
  8. CHEN C, Lim T, Yang A, Lau I, et al
    Risk of Open Conversion During Robotic Gastrectomy for Gastric Cancer: Optimizing Patient Selection.
    J Surg Oncol. 2025 Jul 10. doi: 10.1002/jso.70032.
    >> Share

    June 2025
  9. BATES KR, Jones W, Liggett MR, Zaza NN, et al
    Complications Following Open Versus Minimally Invasive Resection of Gastric Adenocarcinoma.
    J Surg Oncol. 2025;131:1302-1312.
    >> Share

  10. PRELA O, Caveney B, Strawderman M, Linehan D, et al
    A Reassessment of the Clinical Utility of (68)Ga-DOTATATE PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
    J Surg Oncol. 2025;131:1336-1342.
    >> Share

  11. PETTIGREW MF, Kumar P, Nahi SL, Reznik SI, et al
    CT Scans Understage Lymph Nodes in Gastric and Gastroesophageal Adenocarcinoma.
    J Surg Oncol. 2025;131:1571-1579.
    >> Share

    May 2025
  12. ZHOU X, Jiang Y, Xu H, Lin S, et al
    Modified Frailty Index Predicts Prognosis in Patients With Gastric Cancer After Gastrectomy: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2025 May 14. doi: 10.1002/jso.28136.
    >> Share

    March 2025
  13. WANG YC, Liao YJ, Lin WT, Liao SC, et al
    Assessment of Endoscopic Ultrasound for Predicting Preoperative T Staging in Patients With Gastric Adenocarcinoma.
    J Surg Oncol. 2025;131:411-416.
    >> Share

  14. LI MX, Lopez-Aguiar AG, Poultsides G, Rocha F, et al
    Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors.
    J Surg Oncol. 2025;131:473-480.
    >> Share

  15. KELLY NJ, Shafique N, Tortorello GN, Vargas G, et al
    Total Gastrectomy for Gastric Malignancy: Trends Over 15 Years in Major Morbidity, Mortality, and Patient Selection From The National Surgical Quality Improvement Program.
    J Surg Oncol. 2025;131:624-629.
    >> Share

    February 2025
  16. SONG Y, Chen E, Chiang YJ, Yao JC, et al
    Classification of Gastric Neuroendocrine Tumors and Associations With Survival.
    J Surg Oncol. 2025;131:204-211.
    >> Share

    January 2025
  17. DOBRZHANSKYI O, Gaskill CE, Kizub D, Kondratskyi Y, et al
    Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine.
    J Surg Oncol. 2025 Jan 19. doi: 10.1002/jso.28095.
    >> Share

    December 2024
  18. ZHU A, Kosyachkova E, Tiano T, Coburn NG, et al
    Letter to the Editor: Reporting of Core Outcomes in Gastric Cancer Surgical Trials Over the Past 25 Years (Systematic Review).
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28057.
    >> Share

  19. GUL S, Alberto M, Annika K, Pratschke J, et al
    Emerging Treatment Modalities for Gastric Cancer With Macroscopic Peritoneal Metastases: A Systematic Review.
    J Surg Oncol. 2024 Dec 10. doi: 10.1002/jso.27987.
    >> Share

  20. HU Q, Shi J, Yang X
    FLOT x8 for Gastric Cancer: Progress or Premature Optimism?
    J Surg Oncol. 2024 Dec 3. doi: 10.1002/jso.28028.
    >> Share

  21. VITELLO DJ, Zaza NN, Bates KR, Janczewski LM, et al
    Current National Treatment Trends for Gastric Adenocarcinoma in the United States.
    J Surg Oncol. 2024;130:1563-1572.
    >> Share

  22. KHIABANY A, Dermanis AA, Liew MS, Ong KR, et al
    A Systematic Review of Surgical and Pathological Outcomes in Patients With a CDH1 Mutation Undergoing Total Gastrectomy.
    J Surg Oncol. 2024;130:1539-1550.
    >> Share

    November 2024
  23. YIBREHU B, Mohammed TO, Murthy S, Aderibigbe AS, et al
    Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry.
    J Surg Oncol. 2024 Nov 18. doi: 10.1002/jso.27993.
    >> Share

  24. JI ZH, Zhao QD, Li Y
    The Effects of HIPEC on Survival of Gastric Cancer Patients With Peritoneal Metastasis.
    J Surg Oncol. 2024 Nov 17. doi: 10.1002/jso.27877.
    >> Share

    October 2024
  25. KLINGBEIL KD, Eng IK, Dube P, Dillon DL, et al
    CT Imaging as a Single Modality for Clinical Staging of Gastric Cancer in Limited Resource Centers: A Retrospective Pilot Study.
    J Surg Oncol. 2024 Oct 15. doi: 10.1002/jso.27857.
    >> Share

  26. RENCUZOGULLARI A, Karahan SN, Selcukbiricik F, Lacin S, et al
    The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy.
    J Surg Oncol. 2024 Oct 13. doi: 10.1002/jso.27934.
    >> Share

  27. AJAY PS, Mavani PT, Sok CP, Goyal S, et al
    Comparison of treatment strategies based on clinical and pathological nodal status in resectable gastric adenocarcinoma.
    J Surg Oncol. 2024;130:1078-1091.
    >> Share

    September 2024
  28. ARARUNA GF, Ribeiro HSC, Torres SM, Diniz AL, et al
    Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27904.
    >> Share

  29. RAMOS MFKP, Gusmao JS, Pereira MA, Ribeiro-Junior U, et al
    Textbook outcome for evaluating the surgical quality of gastrectomy.
    J Surg Oncol. 2024;130:769-775.
    >> Share

  30. RAMOS MFKP, Pereira MA, Santos SM, Dias AR, et al
    Gastrectomies for the treatment of gastric cancer in a reference cancer center present better pathological results and survival compared to non-specialized hospitals.
    J Surg Oncol. 2024;130:750-756.
    >> Share

  31. PEREIRA MA, Ramos MFKP, Dias AR, Yagi OK, et al
    Adjuvant chemotherapy versus preoperative chemotherapy for gastric cancer treated with curative-intent resection: A propensity score-matched analysis.
    J Surg Oncol. 2024;130:724-733.
    >> Share

  32. DA SILVA GOMES S, Oliveira CS, Furtado TA, Melo LM, et al
    Recurrence of fusocellular subtype GIST with SDHB mutation: A case of SDHB-loss and therapeutic challenges.
    J Surg Oncol. 2024;130:741-742.
    >> Share

  33. LIMA CAC, Martins MR, Dos Santos RL, da Silva LM, et al
    Soluble levels of 4-1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma.
    J Surg Oncol. 2024;130:734-740.
    >> Share

    August 2024
  34. KITAI T, Yamanaka K
    Conversion surgery for gastric cancer with PM.
    J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27794.
    >> Share

    July 2024
  35. TAKAHASHI H, Nakauchi M, Hiotis S, Datta R, et al
    Neoadjuvant chemotherapy for resectable gastric cancer is associated with better outcomes than neoadjuvant chemoradiation.
    J Surg Oncol. 2024 Jul 31. doi: 10.1002/jso.27761.
    >> Share

  36. CASS SH, Williams LA, Rajaram R, Hirata Y, et al
    Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study.
    J Surg Oncol. 2024;130:117-124.
    >> Share

    June 2024
  37. DA SILVA LM, Martins MR, Dos Santos RL, Da Silva JPA, et al
    Evaluation of soluble co-inhibitors and co-stimulators levels of the immune response in gastric cancer.
    J Surg Oncol. 2024 Jun 30. doi: 10.1002/jso.27747.
    >> Share

  38. SOUZA WP, Pereira MA, Cardili L, Zilberstein B, et al
    Evaluation of the endoscopic cure criteria in patients undergoing surgery for early gastric cancer.
    J Surg Oncol. 2024 Jun 27. doi: 10.1002/jso.27745.
    >> Share

  39. JANCZEWSKI LM, Buchheit J, Jacobs RC, Vitello D, et al
    Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage gastric cancer.
    J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27732.
    >> Share

    May 2024
  40. JANCZEWSKI LM, Bentrem DJ, Chawla A
    Response to comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27678.
    >> Share

  41. DA COSTA WL JR,, Tan MC, Camp ER, Thrift AP, et al
    Patient- and system-level factors associated with racial/ethnic disparities in the delivery of guideline-concordant therapy among US patients with gastric cancer.
    J Surg Oncol. 2024 May 16. doi: 10.1002/jso.27683.
    >> Share

  42. CORSO G, Davis JL, Strong VE
    Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
    J Surg Oncol. 2024;129:1082-1088.
    >> Share

    April 2024
  43. LI C, Qu M, Ye Y, Zhu F, et al
    Letter to the Editor: Comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
    J Surg Oncol. 2024 Apr 29. doi: 10.1002/jso.27667.
    >> Share

  44. DIAS AR, Pereira MA, Ramos MFKP, de Oliveira RJ, et al
    Robotic versus laparoscopic gastrectomy for gastric cancer: A Western propensity score matched analysis.
    J Surg Oncol. 2024 Apr 17. doi: 10.1002/jso.27651.
    >> Share

    March 2024
  45. NAQVI A, Matias N, Al-Khaffaf B
    Reporting of core outcomes in gastric cancer surgery trials over the past 25 years (systematic review).
    J Surg Oncol. 2024 Mar 6. doi: 10.1002/jso.27613.
    >> Share

  46. KIM JY, Love M, Woo Y, Campos B, et al
    Pilot study of a telehealth intervention for personalized self-management for eating symptoms after gastroesophageal cancer surgery.
    J Surg Oncol. 2024;129:728-733.
    >> Share

    February 2024
  47. LILLEY EJ, Lu P, Robinson K, Griffith H, et al
    High symptom burden in patients undergoing gastrectomy for cancer.
    J Surg Oncol. 2024;129:228-232.
    >> Share

    January 2024
  48. HONDO N, Yamamoto Y, Nakabe T, Otsubo T, et al
    Short-term outcomes of laparoscopic and robotic distal gastrectomy for gastric cancer: Real-world evidence from a large-scale inpatient database in Japan.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27575.
    >> Share

  49. VAN DER WIELEN N, Brenkman H, Seesing M, Daams F, et al
    Minimally invasive versus open gastrectomy for gastric cancer. A pooled analysis of two European randomized controlled trials.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27578.
    >> Share

  50. SESTITO M, Pratt H, Schmidt C, Thomay A, et al
    Recent advances for treatment of upper gastrointestinal malignancy.
    J Surg Oncol. 2024;129:48-62.
    >> Share

    December 2023
  51. CASPERS IA, Slagter AE, Lind P, Sikorska K, et al
    The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
    J Surg Oncol. 2023 Dec 10. doi: 10.1002/jso.27554.
    >> Share

  52. KARALIS JD, Ju MR, Feig R, Estrella R, et al
    Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites.
    J Surg Oncol. 2023 Dec 8. doi: 10.1002/jso.27556.
    >> Share

    November 2023
  53. JANCZEWSKI LM, Logan CD, Vitello DJ, Buchheit JT, et al
    Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27521.
    >> Share

    October 2023
  54. MAVANI PT, Ajay PS, Goyal S, Shah MM, et al
    Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 17. doi: 10.1002/jso.27483.
    >> Share

  55. LOUAFI MO, Lahnaoui O, Benkabbou A, Majbar MA, et al
    Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 16. doi: 10.1002/jso.27452.
    >> Share

    June 2023
  56. JANCZEWSKI LM, Shah D, Wells A, Bentrem DJ, et al
    The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
    J Surg Oncol. 2023;127:1116-1124.
    >> Share

    April 2023
  57. AJAY PS, Sok CP, Goyal S, Switchenko JM, et al
    Impact of nodal status in determining multimodal treatment strategies in non-cardia gastric cancer.
    J Surg Oncol. 2023 Apr 28. doi: 10.1002/jso.27297.
    >> Share

  58. AJAY PS, NeMoyer R, Goyal S, Switchenko JM, et al
    Does non-metastatic gastric cancer of the cardia warrant a different treatment strategy?
    J Surg Oncol. 2023 Apr 10. doi: 10.1002/jso.27276.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016